PharmaBoardroom

Julie O’Neill, Alexion’s EVP for Global Operations highlights Alexion’s establishment of its Global Supply Chain headquarters in Dublin,…

Dr. Catherine Chammartin of the Swiss Federal Institute of Intellectual Property (IPI) describes the strong elements of an IP system and its…

Professor Mark Ferguson, Director General of Science Foundation Ireland and Chief Scientific Advisor to the Government of Ireland, highlights…

Raul Vivar, recently appointed GM of Eisai Mexico, describes the main achievements of the Japanese company in Mexico, the challenges that innovative…

Ireland is home to Recordati’s external supply operations and global in-licensing teams, alongside the API facility for one of the company’s most…

Peter Kompalla, executive director of the German-Philippine Chamber of Commerce and Industry, discusses the chamber’s activities in the country…

Raúl Riquelme Cacho, president of the health commission of the Confederation of Industrial Chambers of the United Mexican States (CONCAMIN), reveals…

NIBRT's projects director discusses the new 'Biologic' center for biologics research, business development, training, and commercializing the…

The following chart shows the top pharma companies in Hungary ranked by sales value. Global giant Novartis leads the way with USD 240 million of…

Efrén Ocampo, CEO of the Mexican pharmaceutical group Neolpharma, details the strategic thinking that has fostered the emergence of one of the most…

Barry Heavey, Head of Life Sciences at IDA Ireland, Ireland’s inward investment promotion agency, discusses IDA’s focus on acting as a catalyst…

Tuomo Pätsi, President of the EMEA region for Celgene, talks about marking the tenth anniversary of Switzerland as Celgene´s EMEA headquarters;…